1. Signaling Pathways
  2. Immunology/Inflammation
  3. Glycoprotein VI
  4. Glycoprotein VI Inhibitor

Glycoprotein VI Inhibitor

Glycoprotein VI Inhibitors (2):

Cat. No. Product Name Effect Purity
  • HY-P99013
    Codrituzumab
    Inhibitor
    Codrituzumab (GC33) is a humanized monoclonal antibody targeting human GPC3 (glypican-3), with high affinity (Kd of 0.673 nM). GPC3 is an oncofetal protein expressed on the cell surface of hepatocellular carcinoma (HCC). Codrituzumab induces antibody-dependent cellular cytotoxicity (ADCC) and inhibits tumor growth.
  • HY-P990840
    Anti-GPC3 Antibody (YP7)
    Inhibitor
    Anti-GPC3 Antibody (YP7) is a kind of mouse IgG1, κ chimeric antibody, targeting to human GPC3. The recommend isotype control of Anti-GPC3 Antibody (YP7): Mouse IgG1 kappa, Isotype Control (HY-P99977).